The Ethics of Genetic Cognitive Enhancement: Gene Editing or Embryo Selection?
Recent research with human embryos, in different parts of the world, has sparked a new debate on the ethics of genetic human enhancement. This debate, however, has mainly focused on gene-editing technologies, especially CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats). Less attenti...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Philosophies |
Subjects: | |
Online Access: | https://www.mdpi.com/2409-9287/5/3/20 |
_version_ | 1797225832645656576 |
---|---|
author | Marcelo de Araujo |
author_facet | Marcelo de Araujo |
author_sort | Marcelo de Araujo |
collection | DOAJ |
description | Recent research with human embryos, in different parts of the world, has sparked a new debate on the ethics of genetic human enhancement. This debate, however, has mainly focused on gene-editing technologies, especially CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats). Less attention has been given to the prospect of pursuing genetic human enhancement by means of IVF (In Vitro Fertilisation) in conjunction with in vitro gametogenesis, genome-wide association studies, and embryo selection. This article examines the different ethical implications of the quest for cognitive enhancement by means of gene-editing on the one hand, and embryo selection on the other. The article focuses on the ethics of cognitive enhancement by means of embryo selection, as this technology is more likely to become commercially available before cognitive enhancement by means of gene-editing. This article argues that the philosophical debate on the ethics of enhancement should take into consideration public attitudes to research on human genomics and human enhancement technologies. The article discusses, then, some of the recent findings of the SIENNA Project, which in 2019 conducted a survey on public attitudes to human genomics and human enhancement technologies in 11 countries (France, Germany, Greece, the Netherlands, Poland, Spain, Sweden, Brazil, South Africa, South Korea, and United States). |
first_indexed | 2024-03-10T16:36:59Z |
format | Article |
id | doaj.art-8f5534b0972a46a6a0dcd5af18498c1c |
institution | Directory Open Access Journal |
issn | 2409-9287 |
language | English |
last_indexed | 2024-04-24T14:15:17Z |
publishDate | 2020-09-01 |
publisher | MDPI AG |
record_format | Article |
series | Philosophies |
spelling | doaj.art-8f5534b0972a46a6a0dcd5af18498c1c2024-04-03T08:53:37ZengMDPI AGPhilosophies2409-92872020-09-015320010.3390/philosophies5030020The Ethics of Genetic Cognitive Enhancement: Gene Editing or Embryo Selection?Marcelo de Araujo0Faculty of Law, Federal University of Rio de Janeiro, Rio de Janeiro 20211-340, BrazilRecent research with human embryos, in different parts of the world, has sparked a new debate on the ethics of genetic human enhancement. This debate, however, has mainly focused on gene-editing technologies, especially CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats). Less attention has been given to the prospect of pursuing genetic human enhancement by means of IVF (In Vitro Fertilisation) in conjunction with in vitro gametogenesis, genome-wide association studies, and embryo selection. This article examines the different ethical implications of the quest for cognitive enhancement by means of gene-editing on the one hand, and embryo selection on the other. The article focuses on the ethics of cognitive enhancement by means of embryo selection, as this technology is more likely to become commercially available before cognitive enhancement by means of gene-editing. This article argues that the philosophical debate on the ethics of enhancement should take into consideration public attitudes to research on human genomics and human enhancement technologies. The article discusses, then, some of the recent findings of the SIENNA Project, which in 2019 conducted a survey on public attitudes to human genomics and human enhancement technologies in 11 countries (France, Germany, Greece, the Netherlands, Poland, Spain, Sweden, Brazil, South Africa, South Korea, and United States).https://www.mdpi.com/2409-9287/5/3/20gene editingembryo selectionCRISPRcognitive enhancementassisted reproductive technologies (ART)public opinion |
spellingShingle | Marcelo de Araujo The Ethics of Genetic Cognitive Enhancement: Gene Editing or Embryo Selection? Philosophies gene editing embryo selection CRISPR cognitive enhancement assisted reproductive technologies (ART) public opinion |
title | The Ethics of Genetic Cognitive Enhancement: Gene Editing or Embryo Selection? |
title_full | The Ethics of Genetic Cognitive Enhancement: Gene Editing or Embryo Selection? |
title_fullStr | The Ethics of Genetic Cognitive Enhancement: Gene Editing or Embryo Selection? |
title_full_unstemmed | The Ethics of Genetic Cognitive Enhancement: Gene Editing or Embryo Selection? |
title_short | The Ethics of Genetic Cognitive Enhancement: Gene Editing or Embryo Selection? |
title_sort | ethics of genetic cognitive enhancement gene editing or embryo selection |
topic | gene editing embryo selection CRISPR cognitive enhancement assisted reproductive technologies (ART) public opinion |
url | https://www.mdpi.com/2409-9287/5/3/20 |
work_keys_str_mv | AT marcelodearaujo theethicsofgeneticcognitiveenhancementgeneeditingorembryoselection AT marcelodearaujo ethicsofgeneticcognitiveenhancementgeneeditingorembryoselection |